NeuralCIM®

NeuralCIM® (NeuroEPO-plus)

A neuroprotective medication developed in Cuba for the supportive treatment of neurodegenerative diseases.

Frequently Asked Questions

Answers to common questions about NeuralCIM® (NeuroEPO-plus).

NeuralCIM® (NeuroEPO-plus) is a neuroprotective medication developed in Cuba, derived from a modified form of erythropoietin. It is administered intranasally and is intended to support neuronal survival, reduce neuroinflammation, and help stabilize cognitive function in patients with mild-to-moderate Alzheimer's disease and other neurodegenerative conditions.